Become a Patron!

Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026

Status
Not open for further replies.

VUBot

Staff member
Diamond Contributor
ECF Refugee
Vape Media
4023cd4a74b4cffd_sq.webp


Quick Read Direxion Biotech Bull 3X (LABU) doubled over the past year by delivering three times the daily biotech index return. FDA drug approvals often trigger 20% to 50% single-day stock jumps that LABU’s leverage multiplies across its portfolio. Moderna is LABU’s top holding…

Continue reading...
 
Status
Not open for further replies.

VU Sponsors

Top